Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas
Sang Eun Yoon, Junhun Cho, Yeon Jeong Kim, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
W. Thomas Johnson, Nivetha Ganesan, Zachary D. Epstein‐Peterson, et al.
Blood Advances (2023) Vol. 7, Iss. 17, pp. 5172-5186
Open Access | Times Cited: 17
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
Marta Rodríguez, Ruth Alonso‐Alonso, Laura Tomás‐Roca, et al.
Blood Advances (2021) Vol. 5, Iss. 24, pp. 5588-5598
Open Access | Times Cited: 38
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction
Somaya A. Abdel‐Rahman, Brianda L. Santini, Laura Calvo‐Barreiro, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129599-129599
Closed Access | Times Cited: 6
Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop
Sarah L. Ondrejka, Catalina Amador, Fina Climent, et al.
Virchows Archiv (2023) Vol. 483, Iss. 3, pp. 349-365
Open Access | Times Cited: 13
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions
Bettina Bisig, Kerry J. Savage, Laurence de Leval
Haematologica (2023) Vol. 108, Iss. 12, pp. 3227-3243
Open Access | Times Cited: 11
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections
Xiaodan Zheng, Yuanyuan Zheng, Yanlin Zhang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma
Yuta Ito, Joji Shimono, Keisuke Kawamoto, et al.
Leukemia (2025)
Closed Access
Successful treatment of an elderly patient with relapsed/refractory angioimmunoblastic T-cell lymphoma with the PI3Kδ inhibitor linperlisib: a Case Report
Ming‐qiang Chu, Ting‐juan Zhang, Qian Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
Kamila Polgárová, Pavel Otáhal, Cyril Šálek, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
Sang Eun Yoon, Junhun Cho, Yeon Jeong Kim, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 11, pp. e972-e980
Closed Access | Times Cited: 15
First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators
Somaya A. Abdel‐Rahman, Katarzyna Świderek, Moustafa T. Gabr
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1767-1777
Closed Access | Times Cited: 8
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100048-100048
Open Access | Times Cited: 1
Spectrum of lymphomas in India
Susmita Sarma, Jay Mehta
International Journal of Molecular and Immuno Oncology (2024) Vol. 9, pp. 16-24
Closed Access | Times Cited: 1
Clinicopathologic analysis of nodal T-follicular helper cell lymphomas, a multicenter retrospective study from China
Shanshan Ma, Suxiao Li, Xiaona Zuo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Diagnostic Impact of Next-Generation Sequencing Panels for Lymphoproliferative Neoplasms on Small-Volume Biopsies
Fei Fei, Yasodha Natkunam, James L. Zehnder, et al.
American Journal of Clinical Pathology (2022) Vol. 158, Iss. 3, pp. 345-361
Closed Access | Times Cited: 5
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma
Yong-Pyo Lee, Sang Eun Yoon, Junhun Cho, et al.
Annals of Hematology (2022) Vol. 101, Iss. 7, pp. 1535-1543
Closed Access | Times Cited: 5
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma
Suheil Albert Atallah‐Yunes, Michael J. Robertson, Utpal P. Davé
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 9, pp. 659-665
Closed Access | Times Cited: 4
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression
Jin Ho Paik, Jiwon Koh, Bogyeong Han, et al.
Human Pathology (2022) Vol. 131, pp. 47-60
Closed Access | Times Cited: 4
Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies
Jinnan Li, Xianglan Zhu, Xueqin Deng, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 4, pp. 379-394
Closed Access | Times Cited: 2
Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)
Jun Du, Shikai Jin, Minghui Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients
Yunfei Shi, Haojie Wang, Yanfei Liu, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 5, pp. 536-549
Open Access | Times Cited: 2
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024), pp. 100048-100048
Open Access
Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified
Bogyeong Han, Sojung Lim, Jeemin Yim, et al.
Journal of Pathology and Translational Medicine (2024) Vol. 58, Iss. 2, pp. 59-71
Open Access
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type
So-Yeon Choi, Jae‐Cheol Jo, Yoo Jin Lee, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2429-2443
Closed Access
Real-World Data on Clinical Outcomes and Validation of Prognostic Models for Angioimmunoblastic T-cell Lymphoma: A Multicentric Retrospective Study in Southern China
Qiu-Yuan Xiang, Jing-Song Wu, Ling Huang, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top